Is there a stronger allergy medication than Clarityn (loratadine)? For many people in the UK, loratadine provides adequate relief from hay fever, allergic rhinitis, and urticaria — but it does not work equally well for everyone. Some individuals experience only partial symptom control, particularly with moderate-to-severe or year-round allergies. Fortunately, several alternatives exist, ranging from other second-generation antihistamines such as cetirizine and fexofenadine, to prescription options including intranasal corticosteroids, montelukast, and biological therapies. This article outlines the stronger and more targeted allergy treatments available in the UK, with guidance on when to seek professional advice.
Summary: Yes, there are stronger allergy medications than Clarityn (loratadine) available in the UK, including other second-generation antihistamines such as cetirizine and fexofenadine, intranasal corticosteroids, and prescription treatments such as montelukast and omalizumab.
- Loratadine (Clarityn/Clarityn) is a second-generation antihistamine that blocks H1 histamine receptors; it is effective for mild-to-moderate allergic rhinitis and urticaria but may provide insufficient relief for some individuals.
- Cetirizine and fexofenadine are alternative second-generation antihistamines that may offer better symptom control for certain conditions; fexofenadine 120 mg is available over the counter for hay fever, while the 180 mg dose for chronic urticaria requires a prescription.
- Intranasal corticosteroids (e.g., fluticasone, mometasone) are considered the most effective treatment for allergic rhinitis according to NICE CKS guidance and work best when used consistently.
- Montelukast carries an MHRA safety warning (April 2020) regarding potential neuropsychiatric side effects including anxiety, depression, and sleep disturbances; patients must be counselled before starting treatment.
- Omalizumab (Xolair), a biological therapy targeting IgE, is available on the NHS via specialist services for chronic spontaneous urticaria or severe allergic asthma meeting NICE Technology Appraisal criteria.
- Allergen immunotherapy (sublingual tablets or subcutaneous injections) is a longer-term option that modifies the immune response and is supported by NICE for severe grass or birch pollen allergic rhinitis inadequately controlled by standard treatment.
Table of Contents
- How Loratadine (Clarityn) Works and Its Limitations
- Stronger Antihistamines Available in the UK
- Prescription Allergy Treatments on the NHS
- Comparing Allergy Medications: Efficacy and Side Effects
- When to Speak to a GP or Allergy Specialist
- Managing Allergies Safely: NHS and NICE Guidance
- Frequently Asked Questions
Am I eligible for weight loss injections?
Find out whether you might be eligible!
Answer a few quick questions to see whether you may be suitable for prescription weight loss injections (like Wegovy® or Mounjaro®).
- No commitment — just a quick suitability check
- Takes about 1 minute to complete
How Loratadine (Clarityn) Works and Its Limitations
Loratadine, sold under the brand name Clarityn in the UK, is a second-generation antihistamine widely used to relieve symptoms of allergic rhinitis, hay fever, urticaria (hives), and other allergic conditions. It works by selectively blocking H1 histamine receptors, preventing histamine — the chemical released during an allergic response — from binding to tissues and triggering symptoms such as sneezing, itching, a runny nose, and watery eyes.
The standard adult dose is 10 mg once daily. Loratadine is considered less sedating than older, first-generation antihistamines such as chlorphenamine, as it crosses the blood-brain barrier minimally. However, drowsiness can still occur in some individuals, and you should avoid driving or operating machinery until you know how the medicine affects you. It is available over the counter at pharmacies and supermarkets, making it a convenient first-line option for many people.
Loratadine does have limitations. Its efficacy can vary between individuals, and some people find it provides only partial relief from moderate-to-severe allergy symptoms. Onset of effect is typically within one to three hours, with a duration of approximately 24 hours (per the EMC SmPC for loratadine). For allergic rhinitis — particularly perennial (year-round) symptoms — intranasal corticosteroids are generally more effective than antihistamines alone, according to NICE Clinical Knowledge Summaries (CKS). For chronic spontaneous urticaria (CSU), antihistamine monotherapy at standard doses may be insufficient, and specialist input is often required. People with hepatic impairment should seek medical advice before using loratadine, as dose adjustment may be needed. For patients who find Clarityn insufficient, there are several stronger or more targeted options available in the UK.
Stronger Antihistamines Available in the UK
For those who find loratadine inadequate, other second-generation antihistamines are available in the UK and may offer greater symptom relief for some individuals. The most commonly recommended alternatives include:
-
Cetirizine (e.g., Piriteze, Zirtek): Cetirizine is a second-generation antihistamine that may be more effective for skin-related allergic conditions such as urticaria. It has a relatively fast onset of action. The standard adult dose is 10 mg once daily. It can cause mild drowsiness in some people; caution is advised when driving until effects are known.
-
Fexofenadine (e.g., Allevia, Telfast): Fexofenadine is a second-generation antihistamine. In the UK, the 120 mg tablet is available as a Pharmacy (P) medicine for hay fever (allergic rhinitis) in adults and adolescents aged 12 and over; the 180 mg tablet for chronic idiopathic urticaria remains a prescription-only medicine (POM). It is associated with a very low risk of sedation. Importantly, fruit juices (including grapefruit, orange, and apple juice) can significantly reduce fexofenadine absorption — the medicine should be taken with water, not fruit juice (per the EMC SmPC for fexofenadine).
-
Acrivastine (e.g., Benadryl Allergy Relief): This is a shorter-acting antihistamine taken as 8 mg three times daily. It may suit those who prefer flexible dosing. Caution is required in renal impairment, and it should be avoided in severe renal impairment — patients with kidney disease should seek medical advice before use (per the EMC SmPC for acrivastine).
It is worth noting that increasing the dose of any antihistamine beyond the standard recommended amount should only be done under medical supervision. In CSU, specialists may up-titrate non-sedating H1-antihistamines to up to four times the standard dose off-label, in line with NICE CKS and BSACI guidance on chronic urticaria. Patients should always read the patient information leaflet and consult a pharmacist if unsure which antihistamine is most appropriate for their symptoms.
If you experience any suspected side effects from an antihistamine or any other medicine, you can report these via the MHRA Yellow Card scheme at yellowcard.mhra.gov.uk or via the Yellow Card app.
Prescription Allergy Treatments on the NHS
When over-the-counter antihistamines prove insufficient, a GP can prescribe stronger or more targeted allergy treatments through the NHS. These options address different aspects of the allergic response and are typically reserved for moderate-to-severe or persistent symptoms.
Intranasal corticosteroids (e.g., fluticasone, mometasone, beclometasone) are considered the most effective treatment for allergic rhinitis according to NICE CKS guidance. They reduce local inflammation in the nasal passages and are available both on prescription and, increasingly, over the counter. They are most effective when used consistently rather than on an as-needed basis. For moderate-to-severe allergic rhinitis not adequately controlled by either treatment alone, a combined intranasal azelastine and fluticasone spray (Dymista) is available on prescription and may offer additional benefit.
Montelukast is a leukotriene receptor antagonist available on prescription that can be used alongside antihistamines, particularly when asthma co-exists with allergic rhinitis. It is not considered a first-line treatment for rhinitis in the absence of asthma. The MHRA issued a Drug Safety Update in April 2020 highlighting potential neuropsychiatric side effects, including sleep disturbances, anxiety, depression, and mood or behaviour changes. Patients should be counselled about these risks before starting treatment, and should seek prompt medical review if such symptoms occur.
Omalizumab (Xolair) is a biological therapy that works by binding to immunoglobulin E (IgE), reducing the allergic cascade. It is licensed for chronic spontaneous urticaria in patients whose symptoms are inadequately controlled with high-dose H1-antihistamines, and for severe allergic asthma meeting specific criteria. NHS access is subject to NICE Technology Appraisal criteria (e.g., NICE TA339 for CSU). It is administered by injection and is available through specialist allergy or dermatology services.
Allergen immunotherapy (desensitisation) — available as subcutaneous injections (SCIT) or sublingual tablets (SLIT) — is a longer-term treatment that modifies the immune response to specific allergens. In the UK, licensed SLIT tablet products (such as Grazax, Oralair, and Itulazax) are approved for grass or tree pollen allergic rhinitis. NICE Technology Appraisals support their use in adults with severe grass or birch pollen allergic rhinitis that remains inadequately controlled despite optimal pharmacotherapy. Sublingual drops are generally unlicensed in the UK and are not routinely recommended.
Comparing Allergy Medications: Efficacy and Side Effects
Choosing the right allergy medication involves balancing efficacy against tolerability and individual patient factors. The following summarises key considerations:
-
Loratadine (10 mg once daily): Mild-to-moderate efficacy for rhinitis and urticaria; less sedating; suitable for daytime use; onset approximately 1–3 hours.
-
Cetirizine (10 mg once daily): Comparable or potentially better efficacy for urticaria; slightly higher likelihood of drowsiness in some individuals; relatively fast onset.
-
Fexofenadine (120 mg once daily for AR; 180 mg once daily for CSU — POM): Low sedation risk; avoid taking with fruit juices; 120 mg available OTC for hay fever.
-
Intranasal corticosteroids: Highest efficacy for nasal symptoms; minimal systemic absorption at recommended doses; requires consistent daily use for full benefit.
-
Montelukast: Useful adjunct, particularly when asthma co-exists; neuropsychiatric risk requires counselling and monitoring (MHRA DSU, April 2020).
First-generation antihistamines such as chlorphenamine (Piriton) are significantly more sedating and are generally not recommended for daytime use or when driving or operating machinery. They may be appropriate for short-term use at night when sedation is acceptable or even beneficial.
In pregnancy, loratadine or cetirizine are generally preferred based on available UK evidence; however, all medicines in pregnancy should be discussed with a GP or pharmacist before use. For further information, the BUMPS (Best Use of Medicines in Pregnancy) resource provides UK-specific guidance on antihistamine safety in pregnancy and breastfeeding.
No single medication suits everyone. Factors such as age, renal or hepatic function, pregnancy, co-existing conditions (e.g., asthma), and the specific type of allergy all influence prescribing decisions. A pharmacist can provide valuable guidance on over-the-counter choices, while a GP can tailor treatment more precisely. Patients should avoid combining multiple antihistamines without professional advice, as this does not necessarily improve efficacy and may increase the risk of side effects. If you experience a suspected adverse reaction to any medicine, please report it via the MHRA Yellow Card scheme (yellowcard.mhra.gov.uk).
When to Speak to a GP or Allergy Specialist
Whilst many allergy symptoms can be managed effectively with over-the-counter treatments, there are circumstances where it is important to seek professional medical advice.
In line with NICE CKS guidance on allergic rhinitis, a reasonable first step is to try a regular intranasal corticosteroid and/or a non-sedating antihistamine for two to four weeks at recommended doses. You should contact your GP if:
-
Symptoms are not adequately controlled despite a trial of a regular intranasal corticosteroid and/or a non-sedating antihistamine at recommended doses.
-
Allergy symptoms are significantly affecting your quality of life, sleep, work, or daily activities.
-
You experience symptoms year-round (perennial allergic rhinitis), as this may require investigation to identify the trigger.
-
You develop skin reactions such as persistent hives, swelling, or eczema that do not respond to standard treatment.
-
There is any suspicion of anaphylaxis — a severe, life-threatening allergic reaction characterised by throat swelling, difficulty breathing, a rapid drop in blood pressure, or loss of consciousness. If an adrenaline auto-injector (e.g., EpiPen) is available and prescribed, use it immediately, then call 999. If no auto-injector is available, call 999 immediately.
A GP may refer you to an NHS allergy clinic, immunologist, dermatologist (for CSU), or ENT specialist (for rhinitis) depending on your symptoms and local pathways. Referral may involve allergen identification via skin prick testing or specific IgE blood tests, or consideration of immunotherapy. The British Society for Allergy and Clinical Immunology (BSACI) provides guidance on appropriate referral pathways. Early specialist input can prevent unnecessary suffering and reduce the risk of complications, particularly in patients with co-existing asthma or a history of severe reactions.
Managing Allergies Safely: NHS and NICE Guidance
Effective allergy management goes beyond medication alone. NHS and NICE guidance emphasises a holistic approach that combines pharmacological treatment with allergen avoidance strategies and patient education.
Allergen avoidance remains a cornerstone of allergy management. Practical measures include:
-
Monitoring pollen forecasts and limiting outdoor activity on high-pollen days.
-
Using wraparound sunglasses and showering after being outdoors during hay fever season.
-
Regularly washing bedding at high temperatures and using allergen-proof mattress covers for house dust mite allergy.
-
Avoiding known food or chemical triggers where identified.
-
Saline nasal irrigation (e.g., using a saline rinse or spray) can be a safe and helpful adjunct to reduce nasal symptoms and is suitable for most people.
NICE CKS recommends a stepwise approach to allergic rhinitis: starting with a non-sedating antihistamine or intranasal corticosteroid, then combining both if monotherapy is insufficient, before escalating to specialist care. For chronic urticaria, BSACI guidelines support increasing antihistamine doses up to four times the standard dose under medical supervision before considering add-on therapies.
Topical nasal decongestants (e.g., xylometazoline) can provide short-term relief of nasal congestion but should not be used for more than seven days, as prolonged use can cause rebound congestion (rhinitis medicamentosa).
Patient safety is paramount. The MHRA advises that all medicines — including those bought over the counter — should be used strictly in accordance with the product information. Pregnant or breastfeeding women, children, elderly patients, and those with chronic health conditions should always seek pharmacist or GP advice before starting any new allergy treatment. In pregnancy, loratadine or cetirizine are generally preferred; consult BUMPS or your GP for personalised advice.
If you suspect a side effect from any medicine, report it via the MHRA Yellow Card scheme at yellowcard.mhra.gov.uk or via the Yellow Card app.
Finally, keeping a symptom diary can help identify patterns, triggers, and treatment responses, supporting more informed decisions about ongoing management. With the right combination of treatments and lifestyle adjustments, the majority of allergy sufferers can achieve good symptom control and an improved quality of life.
Frequently Asked Questions
Is cetirizine stronger than Clarityn (loratadine) for allergies?
Cetirizine and loratadine are both second-generation antihistamines with broadly similar efficacy for allergic rhinitis, but cetirizine may provide better relief for skin-related conditions such as urticaria in some individuals. Both are taken as a 10 mg once-daily dose, though cetirizine carries a slightly higher likelihood of causing drowsiness, so caution is advised when driving until you know how it affects you.
Can I take a stronger allergy medication than Clarityn without a prescription in the UK?
Yes — cetirizine and fexofenadine 120 mg (for hay fever) are both available over the counter at UK pharmacies without a prescription and may suit people who find loratadine insufficient. A pharmacist can advise on which option is most appropriate for your symptoms, taking into account any other medicines you take or health conditions you have.
What is the difference between fexofenadine and Clarityn for hay fever?
Both fexofenadine and loratadine (Clarityn) are non-sedating second-generation antihistamines used for hay fever, but fexofenadine is associated with a very low risk of drowsiness and is taken with water — not fruit juice, which can significantly reduce its absorption. Fexofenadine 120 mg is available over the counter for allergic rhinitis in adults and adolescents aged 12 and over, while the 180 mg dose for chronic urticaria remains prescription-only in the UK.
Are first-generation antihistamines like Piriton (chlorphenamine) stronger than Clarityn?
First-generation antihistamines such as chlorphenamine (Piriton) are not necessarily more effective than loratadine, but they are significantly more sedating because they cross the blood-brain barrier more readily. They are generally not recommended for daytime use or when driving or operating machinery, though they may be appropriate for short-term use at night when sedation is acceptable.
How do I get a prescription for stronger allergy treatment if Clarityn is not working?
If over-the-counter antihistamines such as loratadine are not providing adequate relief, you should make an appointment with your GP, who can prescribe treatments such as intranasal corticosteroids, montelukast, or — in specialist settings — omalizumab or allergen immunotherapy. NICE CKS guidance recommends trying a regular intranasal corticosteroid and/or non-sedating antihistamine for two to four weeks before escalating care, so it is helpful to keep a note of your symptoms and what you have already tried.
Is it safe to take two different antihistamines together if one is not strong enough?
Combining two antihistamines is not generally recommended, as it does not reliably improve efficacy and may increase the risk of side effects such as drowsiness, dry mouth, and urinary retention. If your current antihistamine is not controlling your symptoms, speak to a pharmacist or GP about switching to a different antihistamine or adding a complementary treatment such as an intranasal corticosteroid rather than doubling up.
The health-related content published on this site is based on credible scientific sources and is periodically reviewed to ensure accuracy and relevance. Although we aim to reflect the most current medical knowledge, the material is meant for general education and awareness only.
The information on this site is not a substitute for professional medical advice. For any health concerns, please speak with a qualified medical professional. By using this information, you acknowledge responsibility for any decisions made and understand we are not liable for any consequences that may result.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Heading 6
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
Block quote
Ordered list
- Item 1
- Item 2
- Item 3
Unordered list
- Item A
- Item B
- Item C
Bold text
Emphasis
Superscript
Subscript
